News

PipelineReview.com4d
Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis
YANTAI, China I April 8, 2025 I On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and ...
RemeGen Co., Ltd: Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis
On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and ...
China Daily5d
China, US can resolve economic, trade differences through dialogue, cooperation: white paper
BEIJING -- China and the United States can resolve differences in economic and trade areas through equal-footed dialogue and ...